Please use this identifier to cite or link to this item:
Title: Pharmacological and cosmeceutical applications of Bixa Orellana L.: A review of the scientific and patent literature
Authors: Pillai, Sindhu
Soni, Seema
Dhulap, Sivakami
Hirwani, R R
Keywords: Annatto;Anti-oxidant;Bixa orellana;Bixin;Lipstick tree;Norbixin
Issue Date: Dec-2018
Publisher: NISCAIR-CSIR, India
IPC Code: Int. cl. (2015.01)- A61K 36/00, A61P 3/00, A61P 31/00, A61P 39/00
Abstract: Medicinal plants or herbs belonging to different traditional medicinal systems have been used as therapeutic agents for curing a number of diseases and infections. Hence, the application of such traditionally known medicinal plants and its phytoconstituents have increased considerably even in modern medicines. Bixa orellana L. — an Indian medicinal plant which belongs to the family Bixaceae is an Ayurvedic herb used since ancient times. This review aims to highlight the ethnopharmacology, pharmacological and cosmeceutical uses of B. orellana not only from scientific literature but also from patent documents. The prior art review of the phytoconstituents shows that B. orellana contains a wide variety of biologically active compounds such as bixin, norbixin, β-carotene, lutein, tocotrienol, tocopherols, sesquiterpenes, monoterpenes, etc. Pharmacological review revealed that this plant is useful as anti-inflammatory, anti-asthma, anti-bacterial, anti-diabetic, anti-convulsant, hepatoprotective, antifungal, anticancer agent. This review also highlights the year wise patent filing trends and the major assignees active in filing patents in this area. Such a review will provide useful insights for further biological or clinical investigations of the bioactive or active fractions from the plant.
Page(s): 281-289
ISSN: 0976-0512 (Online); 0976-0504 (Print)
Appears in Collections:IJNPR Vol.9(4) [December 2018]

Files in This Item:
File Description SizeFormat 
IJNPR 9(4) 281-289.pdf191.14 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.